Enanta Pharmaceuticals, Inc. Common Stock (NASDAQ: ENTA) last traded at $13.47, up 2.59% on the session. The quote above updates while this page is open; the figures below are drawn from Enanta Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Enanta Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker ENTA. Its market capitalisation is $392.32 million.
Valuation measures for Enanta Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $392.32M |
|---|---|
| Enterprise value | $554.70M |
| Price / sales | 6.01 |
| Price / book | 3.88 |
| Beta | 0.97 |
Trailing-twelve-month figures tagged in Enanta Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $65.26M |
|---|---|
| Net income (TTM) | -$63.23M |
| EPS (TTM) | -$2.42 |
| Operating margin | -89.99% |
| Return on equity | -62.56% |
| Cash | $33.42M |
Range and volume for ENTA over the past 52 weeks.
| 52-week high | $17.15 |
|---|---|
| 52-week low | $7.05 |
| Volume | 277.0K |
| Average volume | 210.0K |
| Previous close | $13.13 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.